# Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

> **NCT03577535** · PHASE2 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 15 (actual)

## Conditions studied

- Mucositis Oral

## Interventions

- **DIETARY_SUPPLEMENT:** Oncoxin®

## Key facts

- **NCT ID:** NCT03577535
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-07-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03577535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03577535, "Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03577535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*